Cargando…
Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience
INTRODUCTION: The delipid extracorporeal lipoprotein filter from plasma (DELP) has been approved for the treatment of acute ischemic stroke (AIS) by the China Food and Drug Administration, but its effectiveness and mechanism are not yet fully determined. The purpose of this study was to evaluate the...
Autores principales: | Cui, Yu, Zhou, Zhong-He, Hou, Xiao-Wen, Chen, Hui-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670379/ https://www.ncbi.nlm.nih.gov/pubmed/33091902 http://dx.doi.org/10.1159/000511050 |
Ejemplares similares
-
Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018) -
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017) -
Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase
por: Onder, Seda, et al.
Publicado: (2018) -
Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020) -
Association of serum biomarkers with early neurologic improvement after intravenous thrombolysis in ischemic stroke
por: Cui, Yu, et al.
Publicado: (2022)